Risk Factors of Porphyria Cutanea Tarda (PCT)
Learn more about:
Related Clinical Trial
Study of the Pathogenesis of Porphyria Cutanea Tarda
Harvoni Treatment Porphyria Cutanea Tarda
Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda
Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda
Risk Factors of Porphyria Cutanea Tarda (PCT)
Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda